Clinical presentation of subacute sclerosing panencephalitis in Papua New Guinea.
Eighty-three children presented at Goroka Base Hospital in the Eastern Highlands Province (EHP) of Papua New Guinea over a period of 3 years and 9 months between February 1997 and November 2000 were confirmed to have subacute sclerosing panencephalitis (SSPE). Confirmation of the diagnosis was based on the demonstration of high titres of measles antibodies in the cerebrospinal fluid and/or serum in association with clinical features supportive of SSPE, including characteristic electroencephalographic changes and amplification of measles virus genome by reverse transcriptase polymerase chain reaction in some cases. The mean cerebrospinal fluid and serum enzyme immunoassay antibody levels among the SSPE patients were 38 250 and 860 580, respectively. The mean age of onset of SSPE was 7.9 +/- 2.6 years and ranged between 2 and 14 years. The overall male to female ratio was 1.2:1 and 1.4:1 for EHP.
Mgone
Charles S
CS
Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea. csmgone@amanet-trust.org
Mgone
Joyce M
JM
Takasu
Toshiaki
T
Miki
Kenji
K
Kawanishi
Ryuta
R
Asuo
Peter G
PG
Kono
Jacinta
J
Komase
Katsuhiro
K
Alpers
Michael P
MP
D000293:Adolescent; D017677:Age Distribution; D000367:Age Factors; D000914:Antibodies, Viral / Q000097:blood / Q000134:cerebrospinal fluid; D002648:Child; D002675:Child, Preschool; D004569:Electroencephalography; D005260:Female; D006801:Humans; D008297:Male; D008457:Measles / Q000150:complications; D008458:Measles Vaccine / Q000008:administration & dosage; D008459:Measles virus / Q000276:immunology; D017678:Sex Distribution; D013344:Subacute Sclerosing Panencephalitis / Q000175:diagnosis* / Q000276:immunology / Q000821:virology
D000914:Antibodies, Viral; D008458:Measles Vaccine